{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Poison Pills In the Wake of COVID-19: A Refresher on Terms and Variations of Shareholder Rights Plans",
    "url": "https://www.lexblog.com/2020/08/31/poison-pills-in-the-wake-of-covid-19-a-refresher-on-terms-and-variations-of-shareholder-rights-plans/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-PDVT5Y94",
        "url": "https://www.lexblog.com/lib/PDVT5Y94/"
    },
    "datePublished": "2020-08-31T15:11:26-04:00",
    "dateModified": "2021-03-04T14:55:13-05:00",
    "author": {
        "@type": "Person",
        "name": "David W. Heck, Michael E. Ellis, Louis Rambo, Samuel J. Waldon"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Proskauer Rose LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "The Capital Commitment",
    "about": "Corporate Governance and Compliance",
    "sourceUrl": "https://www.privateequitylitigation.com/?p=2334",
    "sourceStability": "may-move"
}